CSWC 📈 Amundi MSCI Switzerland - Overview
Exchange: PA • Country: France • Currency: CHF • Type: Etf • ISIN: LU1681044993 • Switzerland Equity
CSWC: Swiss, Stocks, Equity, Index, Fund
‣ Company URL: https://first-eagle.amundi.com/ ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Switzerland TME NR CHF
Additional Sources for CSWC ETF
CSWC ETF Overview
| Market Cap in USD | 222m |
| Category | Switzerland Equity |
| TER | 0.25% |
| IPO / Inception | 2018-03-22 |
CSWC ETF Ratings
| Growth 5y | 30.7% |
| Fundamental | - |
| Dividend | - |
| Rel. Strength Industry | -20.8 |
| Analysts | - |
| Fair Price Momentum | 8.99 CHF |
| Fair Price DCF | - |
CSWC Dividends
No Dividends PaidCSWC Growth Ratios
| Growth Correlation 3m | -81% |
| Growth Correlation 12m | 62% |
| Growth Correlation 5y | 54.4% |
| CAGR 5y | 2.60% |
| CAGR/Mean DD 5y | 0.28 |
| Sharpe Ratio 12m | -0.08 |
| Alpha | -9.63 |
| Beta | 0.38 |
| Volatility | 11.20% |
| Current Volume | 6.3k |
| Average Volume 20d | 5.1k |
What is the price of CSWC stocks?
As of December 22, 2024, the stock is trading at CHF 10.13 with a total of 6,290 shares traded.
Over the past week, the price has changed by -2.57%, over one month by -1.76%, over three months by -5.30% and over the past year by +3.48%.
As of December 22, 2024, the stock is trading at CHF 10.13 with a total of 6,290 shares traded.
Over the past week, the price has changed by -2.57%, over one month by -1.76%, over three months by -5.30% and over the past year by +3.48%.
Is Amundi MSCI Switzerland a good stock to buy?
Neither. Based on ValueRay Analyses, Amundi MSCI Switzerland is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 30.74 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CSWC as of December 2024 is 8.99. This means that CSWC is currently overvalued and has a potential downside of -11.25%.
Neither. Based on ValueRay Analyses, Amundi MSCI Switzerland is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 30.74 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CSWC as of December 2024 is 8.99. This means that CSWC is currently overvalued and has a potential downside of -11.25%.
Is CSWC a buy, sell or hold?
Amundi MSCI Switzerland has no consensus analysts rating.
Amundi MSCI Switzerland has no consensus analysts rating.
What are the forecast for CSWC stock price target?
According to ValueRays Forecast Model, CSWC Amundi MSCI Switzerland will be worth about 9.8 in December 2025. The stock is currently trading at 10.13. This means that the stock has a potential downside of -3.26%.
According to ValueRays Forecast Model, CSWC Amundi MSCI Switzerland will be worth about 9.8 in December 2025. The stock is currently trading at 10.13. This means that the stock has a potential downside of -3.26%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 9.8 | -3.3% |